Transcatheter Aortic Valve Replacement and New Conduction Abnormalities/Permanent Pacemaker: Can We Achieve the Intended Implant Depth?

JACC: Cardiovascular Interventions

Volumn 9, Issue 3, 2016, Pages 255-258

  Piazza, Nicolo ^a   Lauzier, Pascal ^a   Mylotte, Darren ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Department of Cardiology   (Ireland)

Author keywords

conduction abnormalities; implant depth; permanent pacemaker; transcatheter aortic valve replacement

Indexed keywords

AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; COMPLETE HEART BLOCK; EDITORIAL; FAINTNESS; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; QRS INTERVAL; SUDDEN CARDIAC DEATH; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTA VALVE; AORTIC VALVE STENOSIS; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; TREATMENT OUTCOME;

AORTIC VALVE; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PACEMAKER, ARTIFICIAL; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84977667741     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.11.034     Document Type: Editorial

References (10)

1. 1 Piazza, N., Onuma, Y., Jesserub, E., et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. J Am Coll Cardiol Intv 3 (2008), 310–316.
2. 2 Husser, O., Pellegrini, C., Kessler, T., et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. J Am Coll Cardiol Intv 9 (2016), 244–254.
3. 3 Eltchaninoff, H., Prat, A., Gilard, A., et al. Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur Heart J 32 (2011), 191–197.
4. 4 Leon, M.B., Smith, C.R., Mack, M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
5. 5 Webb, J., Gerosa, G., Lefèvre, T., et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol 64 (2014), 2235–2243.
6. 6 Tarantini, G., Mojoli, M., Purita, P., et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention 11 (2015), 343–350.
7. 7 Murray, M.I., Geis, N., Pleger, S.T., et al. First experience with the new generation Edwards SAPIEN 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol 28 (2015), 109–116.
8. 8 Binder, R.K., Rodés-Cabau, J., Wood, D.A., et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. J Am Coll Cardiol Intv 3 (2013), 293–300.
9. 9 Binder, R.K., Stortecky, S., Heg, D., et al. Procedural results and clinical outcomes of transcatheter aortic valve implantation in Switzerland: an observation cohort study of SAPIEN 3 versus SAPIEN XT transcatheter heart valves. Circ Cardiovasc Interv, 10, 2015 e002653.
10. 10 El-Khally, Z., Thibault, B., Staniloae, C., et al. Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am J Cardiol 94 (2004), 1008–1011.